1 The White House is making an attempt to influence AI companies to be extra moral
Good luck with that. (NYT $)
+ Everyone appears to agree we want new rules, however the US authorities doesn’t appear to know easy methods to proceed. (WP $)
+ The UK’s competitors watchdog is reviewing the AI market. (The Guardian)
2 The FDA has authorized the primary RSV vaccine
The cold-like virus kills hundreds of Americans every year. (Vox)
3 Google is quickly accelerating its work on AI
Just as requires the trade to sluggish every thing down develop louder. (WP $)
+ Its largest rival, OpenAI, is burning by cash. (The Information $)
+ Microsoft’s AI-powered Bing nonetheless isn’t delivering on its guarantees. (The Atlantic $)
4 Neuralink’s oversights board is riddled with potential conflicts
The majority of its 22 members are its personal workers. (Reuters)
+ Elon Musk’s Neuralink is neuroscience theater. (MIT Technology Review)
5 Bluesky is a haven for Twitter’s marginalized customers
The early adopters hope to form the platform’s neighborhood. (NBC News)
+ We’re witnessing the mind loss of life of Twitter. (MIT Technology Review)
6 What it’ll take to faucet into geothermal vitality in Texas
Drilling pipes into sizzling rocks, controversial fracking and an entire lot of cash. (Wired $)
+ An bold startup desires to drag carbon dioxide straight out of the ocean. (The Verge)
7 Therapy apps aren’t taking care of their customers’ knowledge
Sensitive data is susceptible to interception because of misleading privateness insurance policies. (The Verge)
8 Why e-fuels for EVs aren’t taking off
The trade is paying all its consideration to planes, moderately than Earth-bound autos. (The Guardian)
+ Hydrogen-powered planes take off with startup’s take a look at flight. (MIT Technology Review)